Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Substances from stem cells for the treatment of (neuro-) degenerative diseases

02.11.2012
The new active agents can be used to produce

pharmaceutical substances to be used for the treatment of neurodegenerative diseases. The substances are enriched with dying stem cells. The agents are suited to disable

acute or delayed dysfunctions. They prevent the dying of neuronal cells after acute injuries or during the progress of neurodegenerative disorders.

Further Information: PDF

TransMIT Gesellschaft für Technologietransfer mbH
Phone: +49 (0)641/943 64-12

Contact
Dr. Peter Stumpf

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2960&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht Synthesis of novel Myrtucommulone and Analogues
25.11.2013 | TechnologieAllianz e.V.

nachricht Innovative nozzle design with homogeneous flow profile usable as divergent long-range nozzle with high penetration depth
22.11.2013 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Anzeige

Anzeige

Event News

BrainScaleS Conference: From Neurobiology to New Computer Architectures

25.09.2014 | Event News

17th European Health Forum Gastein: “Electing Health – The Europe We Want”

23.09.2014 | Event News

Future questions regarding data processing

22.09.2014 | Event News

 
Latest News

Stressed Out: Research Sheds New Light on Why Rechargeable Batteries Fail

02.10.2014 | Power and Electrical Engineering

Nanoparticles Accumulate Quickly in Wetland Sediment

02.10.2014 | Ecology, The Environment and Conservation

'Smart' bandage emits phosphorescent glow for healing below

02.10.2014 | Medical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>